Walleye Capital
OMIC

Walleye Capital’s Singular Genomics Systems, Inc. Common Stock OMIC Stock Holding History

Walleye Capital’s Portfolio OMIC Stock Details OMIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-892
Closed -$310K – 2678
2021
Q4 		$310K Buy
+892
New +$346K 0.01% 1235

Other funds holding OMIC

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCM
Revelation Capital Management Sausalito, California $67.4M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Walleye Capital's OMIC Position: Q1 2022 in Review

Walleye Capital sold out of Singular Genomics Systems, Inc. Common Stock (OMIC) in Q1 2022, closing a stake of 892 shares — an estimated $310K sold.

Walleye Capital first reported a position in OMIC in Q4 2021 and held it in 1 quarter. The position peaked at $310K in Q4 2021. 69 funds tracked by Wall St. Rank hold OMIC as of Q1 2022.

  • Walleye Capital reported no remaining Singular Genomics Systems, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • Walleye Capital sold 892 Singular Genomics Systems, Inc. Common Stock shares in Q1 2022, an estimated $310K.
  • Walleye Capital first reported a position in Singular Genomics Systems, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • Walleye Capital's Singular Genomics Systems, Inc. Common Stock position peaked at $310K in Q4 2021.
  • 69 funds tracked by Wall St. Rank held Singular Genomics Systems, Inc. Common Stock as of Q1 2022.

Based on Walleye Capital's 13F filing for Q1 2022, filed 16 May 2022.